What is the preferred chemotherapy regimen for a patient with bladder adenocarcinoma with signet ring features?

Signet ring cell variants are considered an aggressive phenotype of urinary bladder adenocarcinoma with poor outcome. Because of the rarity, evidence based treatment approach is unknown. There are anecdotal experience in the literature.

For example, a long term survival of 90 months was reported for ...